Externally used compound wound plaster prescription

A formula and compound technology, which can be used in the drug formula for chapped treatment and in the field of itchy skin, which can solve the problems of treatment scope and effect limitation.

Inactive Publication Date: 2009-02-18
孟华
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In order to solve the problem that other external ointments have great limitations in the treatment range and effect, the present invention invents a formula for external compound healing ointment that can be used for the treatment of anal itching, anal fissure, perianal chapped, hand and foot chapped and other diseases

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Weigh 6.7 grams of oxytetracycline, 6.7 grams of berberine, 6.7 grams of Yunnan Baiyao, 3.3 grams of metronidazole, 3.3 grams of cimetidine, V C 3.3 grams, C o V B 2.3 grams, 1 gram of borneol, 66.7 grams of petroleum jelly;

[0017] Grinding the above-mentioned medicines except petroleum jelly taken in proportion into powder;

[0018] Pass the drug powder through a No. 6 sieve and mix evenly;

[0019] Heat the vaseline to the melting point and become liquid, and slowly add the uniformly mixed drug powder into the melted vaseline;

[0020] Stir the drug evenly with a glass rod;

[0021] Place the well-stirred medicine to cool;

[0022] Promptly be prepared into 100 grams of compound healing ointments for external use after cooling.

Embodiment 2

[0024] Weigh 3.3 grams of oxytetracycline, 3.3 grams of berberine, 3.3 grams of Yunnan Baiyao, 1.7 grams of metronidazole, 1.7 grams of cimetidine, V C 1.7 grams, C o V B 1.2 grams, borneol 0.5 grams, vaseline 33.3 grams;

[0025] Grinding the above-mentioned medicines except petroleum jelly taken in proportion into powder;

[0026] Pass the drug powder through a No. 6 sieve and mix evenly;

[0027] Heat the vaseline to the melting point and become liquid, and slowly add the uniformly mixed drug powder into the melted vaseline;

[0028] Stir the drug evenly with a glass rod;

[0029] Place the well-stirred medicine to cool;

[0030] Promptly be prepared into 50 grams of compound healing ointments for external use after cooling.

Embodiment 3

[0032] Weigh 10 grams of oxytetracycline, 10 grams of berberine, 10 grams of Yunnan Baiyao, 5 grams of metronidazole, 5 grams of cimetidine, V C 5 grams, C o V B 3.5 grams, 1.5 grams of borneol, 100 grams of petroleum jelly;

[0033] Grinding the above-mentioned medicines except petroleum jelly taken in proportion into powder;

[0034] Pass the drug powder through a No. 6 sieve and mix well;

[0035] Heat the vaseline to the melting point and become liquid, and slowly add the uniformly mixed drug powder into the melted vaseline;

[0036] Stir the drug evenly with a glass rod;

[0037] Place the well-stirred medicine to cool;

[0038] Promptly be prepared into 150 grams of compound healing ointments for external use after cooling.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention provides a formula of external-use compound wound healing ointment, which is characterized in that the formula comprises the following components: oxytetracycline, berberine, metronidazole, CoVB, VC, cimetidine, Yunnan Baiyao, borneol and vaseline, and the proportion of the components is: 6.7 percent of oxytetracycline, 6.7 percent of berberine, 6.7 percent of Yunnan Baiyao, 3.3 percent of metronidazole, 3.3 percent of cimetidine, 3.3 percent of VC, 2.3 percent of CoVB, 1 percent of borneol, and 66.7 percent of vaseline. The ointment has the advantages that the ointment is good in curative effect and fast in action, solves the problems that other external-use ointments have great limitation in the range and effect of dermatosis treatment and are not ideal in curative effect for the pain, extreme itch and skin rhagadia of some serious anorectal diseases, and is especially suitable for treating anal pruritus, anal fissure, perianal rhagadia, hand-foot rhagadia and other skin diseases.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to a medicine formula for treating skin pain, itching and chapped skin. Background technique [0002] At present, common external ointments have great limitations in the scope and effect of skin disease treatment, and the curative effect on some serious anorectal diseases, pain, itching and chapped skin is not ideal, and it cannot immediately solve anal pain and perianal chapped , Pain and itching unbearable problem. Contents of the invention [0003] In order to solve the problem that other external ointments have great limitations in the treatment range and effect, the present invention invents a formula for external compound healing ointment that can be used for the treatment of anal itching, anal fissure, perianal chapped, hand and foot chapped and other diseases . [0004] In order to solve the above-mentioned technical problems, the present invention adopts a technical ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/00A61K9/06A61P17/00A61P17/04A61K31/045A61K31/375A61K31/4164A61K31/4375A61K31/65A61K31/714
Inventor 孟华石青江美芹王勇王炜华
Owner 孟华
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products